Horizon Technology Finance Corp Stock: price and insider trades · United States · SEC (Form 4)Track the Horizon Technology Finance Corp share price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Operating in the Finance & Banking sector, Horizon Technology Finance Corp has logged 28 public disclosures. Market capitalisation: €311.3m. The latest transaction was filed on 10 June 2026 (Acquisition). Among the most active insiders: Michaud Gerald A.. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,013 of 29,062 companies
FCF yld 18%
Earn yld -0.8%
EV/EBITDA ·
ROE 1.4%
Gross mgn ·
Net mgn -37%
Debt/EBITDA ·
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 10 June 2026
All Executives28 Thresholds0 Prospectus0 Other0
Declarations 28 total
▲ Director · Executives · 9 Jun 2026
6,000 shares Common Stock SEC:0000945621-26-000816:0
Canonical exit: 7 Sept 2026 (T+90) ◆ Chief Executive Officer · Executives · 14 Apr 2026
93,527 shares Common Stock SEC:0001437749-26-020103:0
▲ Chief Executive Officer · Executives · 9 Jun 2026
100,000 shares Common Stock SEC:0001437749-26-020103:1
Canonical exit: 7 Sept 2026 (T+90) ▲ Director · Executives · 9 Jun 2026
6,000 shares Common Stock SEC:0001437749-26-020170:0
Canonical exit: 7 Sept 2026 (T+90) ◆ Director · Executives · 14 Apr 2026
49,926 shares Common Stock SEC:0000945621-26-000574:0
◆ Chief Executive Officer · Executives · 14 Apr 2026
93,527 shares Common Stock SEC:0001437749-26-012279:0
◆ Chief Investment Officer · Executives · 14 Apr 2026
142 shares Common Stock SEC:0001437749-26-012280:0
▲ Director · Executives · 16 Dec 2024
20,000 shares @ US$8.53 62.7% of flow Common Stock SEC:0001437749-24-037709:0
Canonical exit: 16 Mar 2025 (T+90) ▲ President · Executives · 25 Nov 2024
8,000 shares @ US$9.3149 13.8% of flow Common Stock SEC:0001437749-24-036405:0
Canonical exit: 23 Feb 2025 (T+90) ▲ Director · Executives · 13 Nov 2024
5,000 shares @ US$9.35 20.2% of flow Common Stock SEC:0001437749-24-035325:0
Canonical exit: 11 Feb 2025 (T+90) ▲ Director · Executives · 5 Aug 2024
10,000 shares @ US$10.58 37.3% of flow Common Stock SEC:0001437749-24-024617:0
Canonical exit: 3 Nov 2024 (T+90) ▲ Director · Executives · 5 Aug 2024
2,313 shares @ US$10.81 100.0% of flow Common Stock SEC:0001437749-24-024620:0
Canonical exit: 3 Nov 2024 (T+90) ▲ President · Executives · 8 Mar 2024
3,650 shares @ US$11.77 7.6% of flow Common Stock SEC:0001437749-24-007312:0
Canonical exit: 6 Jun 2024 (T+90) ▲ President · Executives · 20 Dec 2022
18,250 shares @ US$11.03 36.9% of flow Common Stock SEC:0001437749-22-029511:0
Canonical exit: 20 Mar 2023 (T+90) ▲ CEO and Chairman of the Board · Executives · 9 Dec 2022
4,000 shares @ US$13.03 20.1% of flow Common Stock SEC:0001437749-22-028839:0
Canonical exit: 9 Mar 2023 (T+90) ▲ President · Executives · 6 Dec 2022
4,000 shares @ US$12.90 9.6% of flow Common Stock SEC:0001437749-22-028617:0
Canonical exit: 6 Mar 2023 (T+90) ▲ Executive VP and CFO · Executives · 16 Nov 2022
758 shares @ US$13.04 66.9% of flow Common Stock SEC:0001437749-22-027595:0
Canonical exit: 14 Feb 2023 (T+90) ▲ Director · Executives · 29 Sept 2022
500 shares @ US$9.88 100.0% of flow Common Stock SEC:0001437749-22-023280:0
Canonical exit: 28 Dec 2022 (T+90) ▲ CHIEF EXECUTIVE OFFICER · Executives · 21 Jun 2022
4,000 shares @ US$11.30 0.015% mcap 21.9% of flow Common Stock SEC:0001415889-22-006833:0
Canonical exit: 19 Sept 2022 (T+90) ▲ Director · Executives · 16 May 2022
10,000 shares @ US$12.23 0.040% mcap 67.3% of flow Common Stock SEC:0001415889-22-005108:0
Canonical exit: 14 Aug 2022 (T+90) ▲ Director · Executives · 12 May 2022
5,000 shares @ US$11.82 0.020% mcap 32.7% of flow Common Stock SEC:0001415889-22-004917:0
Canonical exit: 10 Aug 2022 (T+90) ▲ PRESIDENT · Executives · 9 May 2022
3,050 shares @ US$12.06 0.012% mcap 21.1% of flow Common Stock SEC:0001415889-22-004822:0
Canonical exit: 7 Aug 2022 (T+90) ▲ CFO · Executives · 10 May 2022
414 shares @ US$12.00 0.0016% mcap 100.0% of flow Common Stock SEC:0001415889-22-004829:0
Canonical exit: 8 Aug 2022 (T+90) ▲ CHIEF EXECUTIVE OFFICER · Executives · 6 May 2022
4,000 shares @ US$12.726 0.017% mcap 24.6% of flow Common Stock SEC:0001415889-22-004765:0
Canonical exit: 4 Aug 2022 (T+90) ▲ CHIEF EXECUTIVE OFFICER · Executives · 6 Dec 2021
2,500 shares @ US$16.11 0.012% mcap 18.1% of flow Common Stock SEC:0001415889-21-005736:0
Canonical exit: 6 Mar 2022 (T+90) 25 of 28 declarations
Load more (3 remaining) 关于 Horizon Technology Finance Corp Horizon Technology Finance Corp. 是一家在美国上市的专业金融公司,在纳斯达克交易,股票代码为 HRZN。该公司于2010年3月16日注册为特拉华州公司,作为一家非多元化、外部管理的业务发展公司(BDC)运营。其运营中心位于康涅狄格州法明顿,并在加利福尼亚州设有分支机构,这突显了其专注于美国市场的平台,旨在服务国内风险投资和增长融资市场。([sec.gov](https://www.sec.gov/Archives/edgar/data/1487428/000143774926006636/R12.htm?utm_source=openai))
Horizon 的核心业务是向风险投资支持和私募股权支持的公司以及目标行业的上市成长型企业提供有担保贷款。历史上,其贷款重点集中在科技、生命科学、医疗保健、医疗服务和可持续发展相关业务。实际上,Horizon 是一家专业的信贷投资者,通过结构性债务投资寻求收入,并在某些情况下通过认股权证头寸获得股权挂钩的上涨潜力。([sec.gov](https://www.sec.gov/Archives/edgar/data/1487428/000143774925017203/ex_818593.htm?utm_source=openai))
从竞争角度来看,Horizon 在美国金融领域占据了一个利基市场:风险贷款和专业金融。其竞争优势来自于行业专业化、资产支持或担保结构中的承销纪律,以及与风险投资生态系统的紧密关系。这种专业化使其有别于广泛的贷款机构,但也意味着该公司更容易受到信用风险、其投资组合公司估值波动以及影响创新驱动型企业的资本市场周期的影响。([sec.gov](https://www.sec.gov/Archives/edgar/data/1487428/000143774925017203/ex_818593.htm?utm_source=openai))
近期发展突显了投资组合业绩和公司活动。在2026年3月发布的2025年第四季度和全年业绩公告中,该公司报告称,总投资组合为647.2 million美元,净资产价值为318.5 million美元,即每股6.98美元,2025年第四季度的年化债务投资收益率为14.3%。Horizon 还披露,截至年底,已承诺的积压订单为154 million美元。此外,该公司于2026年宣布,涉及 Monroe Capital Corporation 的合并正在推进中,HRZN 有望继续作为存续的纳斯达克上市公司。([sec.gov](https://www.sec.gov/Archives/edgar/data/1512931/000143774926006801/hrzn20260303c_425.htm?utm_source=openai))
对于法语投资者而言,HRZN 最好被视为一家在美国上市的以收入为导向的专业金融股票,与科技和医疗保健成长型公司的融资相关,其收益驱动型特征对信贷质量和美国利率环境高度敏感。